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Abstract
Background: Binding of peptides to MHC class I molecules (MHC-I) is essential for antigen presentation to cytotoxic T-cells.
Results: Here, we demonstrate how a simple alignment step allowing insertions and deletions in a pan-specific MHC-I
binding machine-learning model enables combining information across both multiple MHC molecules and peptide lengths.
This pan-allele/pan-length algorithm significantly outperforms state-of-the-art methods, and captures differences in the
length profile of binders to different MHC molecules leading to increased accuracy for ligand identification. Using this
model, we demonstrate that percentile ranks in contrast to affinity-based thresholds are optimal for ligand identification due
to uniform sampling of the MHC space.
Conclusions: We have developed a neural network-based machine-learning algorithm leveraging information across
multiple receptor specificities and ligand length scales, and demonstrated how this approach significantly improves the
accuracy for prediction of peptide binding and identification of MHC ligands. The method is available at www.cbs.dtu.dk/
services/NetMHCpan-3.0.
Background
Binding of peptides to MHC (major histocompatibility
complex) molecules is a prerequisite for a peptide to be an
immunogen. The MHC class I molecule is highly specific,
engaging in binding with only a minute proportion of the
peptides offered through the antigen presentation pathway
[1]. This property makes binding to the MHC molecule the
single most selective step in antigen presentation. Given the
pivotal role of the MHC, significant efforts have been dedi-
cated to the development of methods capable of accurately
predicting this event. These methods generally fall into two
groups: allele-specific, where a method is trained for every
individual MHC molecule; and pan-specific, where a single
method is trained on data covering multiple MHC mole-
cules. In particular, the latter methods have proven very
powerful as they allow for binding predictions to all MHC
molecules, including those characterized with limited or no
binding data [2, 3]. This aspect becomes extremely import-
ant if we consider the huge polymorphism of MHC genes,
with several thousand allelic variants identified to date in
the HLA loci [4]. Examples of the two types of prediction
tools are (reflected by high performance in the IEDB weekly
automated MHC class I benchmark [5]): allele-specific
(NetMHC [6, 7], SMM [8, 9]) and pan-specific (NetMHC-
pan [2, 3], NetMHCcons [10]). Note that many other tools
have been proposed, but it is out of the scope of the paper
to review them all.
Most accurate methods for prediction of binding to
MHC are data-driven, meaning that the methods are
trained on peptide data with experimental information
about the binding affinity to the MHC molecule in ques-
tion. A prerequisite for the development of accurate data
driven prediction method is the availability of large and
accurate datasets [11]. All the methods mentioned above
obtain these data from the IEDB. These data have a large
bias toward peptides of length 9 (>73 % of the data are for
9mers, whereas <3 % of the data are for peptides of length
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11) (http://tools.immuneepitope.org/main/datasets, data-
set used for retraining the IEDB class I binding prediction
tools). This bias in peptide length has great implications
for the accuracy of binding predictions as the performance
of the methods in general will be poor for lengths different
from nine. We have previously suggested a simple ap-
proximation approach that uses neural networks trained
on 9mer data to extrapolate predictions for peptides of
lengths other than 9 [12]. This approximation is currently
used in the NetMHCpan method. However, in the context
of NetMHCpan this approach is clearly suboptimal as it
completely ignores the information contained in data with
a peptide length different from nine amino acids.
Many MHC binding prediction methods suffer from an-
other serious limitation: they cannot capture the prefer-
ences of MHC allelic variants in terms of peptide length
(what we will call the “length profile”). Even though most
MHC molecules prefer to bind 9mer peptides, experimen-
tal data have demonstrated that the length profiles differ
substantially between MHC molecules, with prominent ex-
amples being the mouse H-2-Kb with a preference for eight
amino acids-long peptides [13] and HLA-A*01:01 where
close to 35 % of bound peptides have a length longer than
nine amino acids [14]. For an allele-specific method, we
have recently demonstrated how a simple alignment step
allowing for insertions/deletions in the peptide data could
integrate information across peptides of different lengths
into one prediction method, not only leading to improved
prediction accuracy in terms of binding affinity but also
capturing differences between MHC molecules in terms of
preferred length of the bound peptides [15].
Here, we incorporate this new alignment step in the train-
ing strategy with the goal to investigate whether it can boost
the predictive performance also in the pan-specific case by
integrating information from datasets comprising peptides of
different lengths. We further analyze if the pan-specific ap-
proach can capture the differences in the length profile of
different MHC molecules, and quantify to what degree the
method leads to improvement in performance when predict-
ing MHC ligands. Lastly, we apply the new method to ad-
dress the issue of the binding threshold for optimal
identification of MHC ligands, and investigate whether a per-
centile rank threshold rather than an affinity threshold is op-
timal when performing rational epitope screening across
multiple MHC molecules.
Implementation
Data
The MHC class I binding dataset was downloaded from
the IEDB [16] (http://tools.immuneepitope.org/main/data-
sets; dataset used for retraining the IEDB class I binding
prediction tools). This dataset consists of 186,684 peptide-
MHC binding affinity measurements covering 172 MHC
molecules from human, mouse, primates, cattle, and swine.
We introduced 25 random natural peptides for each of the
lengths 8, 9, 10, and 11 as artificial negatives for each allele,
to ensure a sufficiently diverse set of negative examples [3].
These random sequences were only used for training and
were excluded from all evaluations. The data were split into
five partitions for cross-validation as described earlier [17]
to ensure that no identical 8mer segment was shared be-
tween partitions.
Network training and architecture
Networks were trained as previously described [3],
encoding each MHC molecule in terms of a pseudo se-
quence in order to leverage information between MHC
molecules. Moreover, we extended this pan-specific ap-
proach by allowing insertions and deletions in the multiple
sequence alignment as described by Andreatta and Nielsen
[15]. In short, the amino acid sequence of training examples
was Blosum encoded using 20 values corresponding to the
BLOSUM matrix scores vector [7]. Peptides longer than
nine amino acids were reduced to a core of nine
amino acids by applying consecutive amino acid dele-
tions. These included both deletions at the end termi-
nals and consecutive deletions within the peptide. In
the case of peptides shorter than nine amino acids, a
wildcard amino acid X (encoded as a vector of zeros)
was inserted to extend the peptide to a 9mer core.
Deletions and insertions were attempted at all pos-
sible locations within the peptide and the configur-
ation returning the highest predicted score was saved
as the optimal binding core. The current best solution
was used together with the MHC pseudo sequence for
error back-propagation and the procedure was iterated.
Other features of the training examples that were
presented to the neural networks are: the length of the
deletion/insertion; the length of peptide flanking regions,
which are larger than zero in the case of a predicted ex-
tension of the peptide outside either terminus of the
binding groove; and the length L of the peptide, encoded
with four input neurons corresponding to the four cases
L < =8, L = 9, L = 10, L > =11. As for the original
NetMHCpan method, the hidden layer of the networks
consisted of 56 or 66 hidden neurons and the output
layer of one neuron having as target value the binding
affinity of the training example rescaled between 0 and 1
using the relationship 1-log(aff )/log(50,000), where aff is
the IC50 affinity value in nM units [7].
Networks were trained in five-fold cross-validation
using gradient descent back-propagation with early
stopping. Ensembles were generated by training five
networks for each data partition and network archi-
tecture each starting from a distinct random initial
configuration, leading to an ensemble of 10 networks
for each data partition, and a total of 50 networks
across all partitions. The ensemble trained on all alleles
Nielsen and Andreatta Genome Medicine  (2016) 8:33 Page 2 of 9
and all peptide lengths will be referred to as the “allmer”
method.
For comparison, a network ensemble was trained using
only the subset of 9mer peptides (“9mer” method) from
the five data partitions described above. As in
NetMHCpan-2.8, the L-mer approximation described by
[12] was used for the networks trained on 9mer data
only to extrapolate predictions for peptides of length dif-
ferent from nine. The L-mer approximation relies on
networks trained only on 9mers, inserting/deleting
amino acids at non-anchor positions in shorter/longer
query peptides to conform the peptides to a series of
9mers and then averaging the predictions of the 9mer
sequences.
Likewise, an ensemble of allele-specific networks was
trained on peptides of multiple lengths (“allmer-allele”
method) using the NetMHC-4.0 method described re-
cently by Andreatta and Nielsen [15].
SYFPEITHI evaluation data
As an independent evaluation set, we extracted a set of
2329 unique MHC class I ligands of length 8–11 from
the SYFPEITHI database [14], excluding all peptide –
MHC pairs found in the training set. To remove poten-
tial noise imposed by wrong annotation of the MHC
restriction element and/or incorrect definition of the
minimal ligand binding core, a filter was applied as pre-
viously described [15] and all peptide-MHC pairs with a
predicted rank score >10 % (calculated using both
NetMHCpan-2.8 and the pan-specific allmer method de-
veloped here) were removed, resulting in a set of 2147
MHC ligands. The source protein sequence of each vali-
dated ligand was scanned with a sliding window of 8–11
amino acids to generate all possible 8, 9, 10, and 11mers
contained in the protein. These overlapping peptides
were then ranked by predicted binding affinity, and for
each protein we measured the relative rank of the vali-
dated ligand in the list of affinity predictions. The rank
of the known ligand measures the fraction of peptides in
the protein that would have to be tested before identify-
ing the actual positive and can be used as a metric of
predictive performance.
Statistical tests
The predictive performances of alternative methods
are compared using binomial tests. The null hypoth-
esis is that either of the two methods being compared
has equal probability of returning higher PCC (or
AUC) on a given MHC allele. If method 1 has higher
PCC in n1 alleles and method 2 higher PCC in n2
alleles, we estimate the p value of this event as the
probability of observing n1 or more wins by chance
in a binomial distribution B(n1 + n2, 0.5). Note that
ties are excluded.
Information divergence
The information divergence is calculated as I ¼Pa f a
log f aba
 
, where the sum is over the alleles included in
the analysis, fa is the observed frequency of allele a (the
proportion of peptides predicted to bind allele a), and ba
is the background frequency of allele a (the proportion
of peptides with predicted binding to allele a irrespec-
tively of binding value).
Results
We have previously demonstrated how a pan-specific
training approach that allows for leveraging of binding
information across multiple MHC molecules leads to a
significant boost in predictive performance for alleles
covered with limited or even no binding data [2]. Like-
wise, we have recently shown that a method exploiting
binding information from peptides of different lengths
can boost the predictive performance for all peptide
lengths, in particular for those covered by limited bind-
ing data [15]. In this work, we aim to investigate
whether combining these two approaches into a pan-
allele, pan-length training pipeline would lead to a fur-
ther improvement in predictive performance for MHC
class I binding prediction.
Comparing a pan-specific method trained on 9mer data
only (9mer) to a pan-specific method trained on data
covering multiple lengths (allmer)
Two ensembles of pan-allele networks were trained
and evaluated using cross-validation as described in
Materials and Methods: allmer includes all binding
data from the IEDB dataset and 9mer includes only
9mer data. For each allele-length combination charac-
terized with at least three binders (defined using a
threshold of 500 nM) and 20 data points, the predictive
performance was estimated in terms of the Pearson’s cor-
relation coefficient (PCC) and area under the ROC curve
(AUC). Figure 1 shows the average performance values for
the two methods for different peptide lengths (results for
all alleles are available in Additional file 1).
The allmer method outperformed the 9mer method at
all length scales. The difference is statistically significant
at all length scales except for peptides of length 11 or
longer (binomial tests excluding ties).
Comparing an allele-specific method trained on peptides
of multiple lengths (allmer-allele) to a pan-specific
method trained on peptides of multiple lengths (allmer)
Next, we compared the predictive performance of the
allmer networks (pan-specific when it comes to both
alleles and peptide length) to a method (allmer-allele)
that is trained in an allele-specific manner on data
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covering multiple peptide lengths (i.e. pan-specific only
when it comes to the peptide length). Here, the allmer
networks were trained as described above, and the
allmer-allele method as described for NetMHC-4.0 [15].
As above, the predictive performance was estimated in
terms of the PCC and AUC for each allele-length
combination characterized with at least three binders
(defined using a threshold of 500 nM) and at least 20
data points shared between the two datasets. Figure 2
shows the average performance values for the two
methods for different peptide lengths (results for all al-
leles are available in Additional file 2).
The allmer approach showed higher average PCC and
AUC on most peptide lengths, although the difference is
statistically significant only for 9mers and 10mers.
Focusing in particular on the subset of alleles character-
ized by few data points (less than five peptide binders),
we find that the allmer method consistently (16 out of
18 cases) achieves a higher predictive performance in
terms of PCC compared to the allmer-allele method
(data in Additional file 2). This result confirms the
earlier finding that the pan-specific training procedure is
capable of leveraging information across different allele
datasets boosting performance for alleles characterized
by limited experimental data [3].
Peptide length preferences of MHC binders
Having demonstrated the superior performance of the
allmer method compared to the allele-specific and
length-specific versions, we proceed to investigate the
peptide length preferences of individual MHC mole-
cules. On the set of 24 MHC alleles characterized with
20 or more ligand data in the SYFPEITHI database, we
predicted binding affinity values for 1,000,000 random
natural peptides with a length of 8–11 amino acids
(250,000 peptides for each length) using the allmer and
9mer models (using the L-mer approximation to predict
binding for non-9mer peptides). We estimated a peptide
length histogram of the MHC molecules by taking the
top 1 % (10,000) predicted binders to each MHC allele.
Fig. 1 Predictive performance on different peptide lengths for the allmer and 9mer predictive methods. The two methods were trained as
described in the text. The predictive performance was measured in terms of Pearson’s correlation coefficient (PCC) and area under the ROC curve
(AUC), the latter using a binding threshold of 500 nM. The allmer method significantly outperforms the 9mer approach on peptides of all lengths
from 8 to 10 (binomial test excluding ties). **: p < 0.001, *: p < 0.05
Fig. 2 Predictive performance on different peptide lengths for the allmer and allmer-allele predictive methods. The two methods were trained as
described in the text. The predictive performance was measured in terms of Pearson’s correlation coefficient (PCC) and area under the ROC curve
(AUC), the latter using a binding threshold of 500 nM. The allmer method significantly outperforms the allmer-allele approach for peptides of
length 9 and 10 (binomial test excluding ties). **: p <0.001, *: p <0.05
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Figure 3 shows the average length histograms for the
two methods. For comparison, we included in the graph
the average of the length histograms estimated from the
ligand data in the SYFPEITHI database (the complete
set of allele-specific histograms for the three methods is
found in Additional file 3).
The results displayed in Fig. 3 show that: (1) MHC
molecules in general have a pronounced preference for
presenting 9mer peptides; (2) the conventional 9mer
method based on the L-mer approximation does not
capture this preference and predicts a close to uniform
fraction of binders at all peptide lengths; and (3) only
the allmer approach, leveraging information across pep-
tide lengths, can predict a length preference that follows
the length distribution trend of experimental data.
These observations are in agreement with earlier find-
ings derived from an allele-specific training pipeline
which made use of peptides of multiple lengths [15].
Focusing once more on alleles characterized by limited
data and in particular datasets with limited data available
for non-9mer peptides, we find that, in contrast to a
method trained in an allele-specific manner, the allmer
approach also for these alleles predicts a length profile
tolerating non-9mer binders (see examples of such al-
leles in Fig. 4). The length profiles obtained from elution
data from the SYFPEITHI and IEDB databases for the
molecules HLA-B*39:01 and HLA-C*04:01 (only three
ligand data points are available for HLA-A*69:01) are
close to identical with a preference for 9mers (74 %)
followed by 8mers (13 %) and 10mers (10 %). Although
the predicted distribution does not coincide perfectly
with the distribution of eluted peptides, the allmer
method clearly provides a better description of the
length profile compared to the allele-specific method.
The pan-specific method has therefore the powerful
property of inferring a length profile of a given MHC
molecule even with scarce experimental data. In the next
section, we investigate how this aspect can positively
affect the identification of new MHC ligands.
Identifying MHC ligands
Next, we aimed to quantify how the gain in predictive
performance brought by the pan-allele/pan-length ap-
proach translates into reduction of cost for identifying
MHC ligands. We obtained a dataset of 2154 ligands
from the SYFPEITHI database consisting of 8–11mer
ligands with known MHC restriction (see Materials
and Methods). Using the 9mer and allmer prediction
methods, we predicted binding to the given MHC restric-
tion element for all 8–11mer peptides in the source pro-
teins of the ligand. Next, for all MHC-ligand-source
protein combinations, we extracted a given proportion of
top scoring peptides (percentage selected), and calculated
the percentage of the 2154 ligands contained within this
selected peptide set (percentage identified). Varying the
percentage selected, we can thus construct the curves pre-
sented in Fig. 5.
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Fig. 3 Length preference for the allmer and 9mer prediction
methods compared to the length preference in the SYFPEITHI data.
Length profiles for the allmer and 9mer methods were estimated
as described in the text. The SYFPEITHI length preference was
estimated as the average over the allele-specific length preference
of 24 MHC molecules characterized by 20 or more ligand data points
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Fig. 4 Comparison of the predicted length profile for alleles
characterized by no or limited peptide data of length different from
nine amino acids. The distribution of predicted binders for the three
alleles were characterized by relatively large data sets (>500 data
points) with more than 99 % 9mers. Length profiles were estimated
from the top 1 % of 1,000,000 random natural 8–11mer peptides
using the allmer-allele (the method trained on allmer data in an
allele-specific manner), and the allmer (the pan-specific method
trained on allemer data) methods, respectively
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The analysis confirms the enhanced predictive per-
formance of the allmer method compared to 9mer ap-
proach. If the top 0.025 % (the first point on the two
curves) of predicted binders are selected for each MHC-
ligand source protein, allmer identifies 47 % of the
known ligands, whereas only 42 % are identified using
9mer. Similarly, if 75 % of the ligands are to be identi-
fied, 0.62 % of all 8–11mer peptides need to be tested by
using allmer. This number is increased by 23 % to
0.76 % using 9mer. Although this difference is small, it
translates into a substantial cost reduction in screening
for peptide ligands in large datasets consisting of thou-
sands of proteins. By way of example, the top 0.76 % of
all 8–11mer peptides in a set of 1000 proteins of average
length 300 amino acids would correspond to 2280 pep-
tides. In this situation, the reduction by 23 % achieved
by the allmer method will correspond to 420 peptides.
Percentile rank score for known ligands/epitopes.
How many MHC ligands are captured at different rank
scores?
Earlier studies have demonstrated that different MHC
molecules present ligands/epitopes at distinct binding
thresholds [18, 19]. Considering the predicted binding
values of the allmer method described here, this situ-
ation also holds true. We observed a large difference in
the proportion of predicted peptide binders at any fixed
affinity value across different MHC molecules. Limiting
the comparison to HLA molecules characterized with at
least 20 binders (defined using a threshold of 500 nM)
and 100 data points, we find for instance that the mol-
ecule HLA-A*02:11 binds more than 7 % of random nat-
ural 9mer peptides with a binding affinity of 500 nM or
stronger. In strong contrast to this, the HLA-C*04:01
molecule was predicted to bind less than 0.01 % of the
same set of natural 9mer peptides at this binding thresh-
old. Given these very large differences in binding affinity
values between MHC molecules, we and others have
earlier suggested that using percentile thresholds rather
than binding affinity values would result in peptide
selection that is less influenced by this variation in pres-
entation threshold, and subsequently when sampling
multiple MHC molecules in one peptide selection would
lead to a dataset with a higher sensitivity and specificity
compared to a selection based on affinity [20]. Using the
SYFPEITHI dataset, we examined this issue using the
allmer prediction method. The analysis was done in a
similar manner to what we described above, but in
addition we translated the predicted binding values to a
percentile score by comparing them to the predicted
binding affinities of a set of 400,000 random natural 8–
11mer peptides (100,000 of each length). We performed
this transformation to percentile rank scores for each al-
lele. Next, we pooled peptides from all source proteins
and MHC restrictions and from this dataset calculated
ROC curves based on either affinity or percentile rank
scores (Fig. 6). From this analysis, it is clear that using
the percentile rank scores consistently achieves higher
sensitivity at all specificity levels. In particular, we find
that 91 % of the ligands are recovered with a specificity
of 98 % at a rank threshold of 2 %. For the affinity
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Fig. 5 Rank analysis on the SYFPEITHI ligand benchmark. Binding to
the restriction element was predicted for all 8–11mer peptides within
the source proteins from the SYFPEITHI data set using the allmer and
9mer prediction methods, respectively. The percentage of identified
ligands is plotted as a function of the percentage of top predicted
binders from each source protein-ligand-MHC combination
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Fig. 6 ROC curve analyses for the SYFPEITHI benchmark dataset.
Binding to the restriction element was predicted for all unique
8–11mer peptides within the source proteins from the SYFPEITHI
benchmark using the allmer method. Binding values were reported
as binding affinity and percentile rank values as described in the
text. ROC curves were calculated for each prediction value taking
ligands as positives and all other peptides as negatives. The inset
plot shows the information divergence value (ID) as a function of
the percentage of peptides selected. The ID was calculated from the
proportion of peptides with predicted restriction to each of the
MHC molecules in the benchmark compared to the proportion
expected by sampling at random
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selection, the sensitivity at this specificity value falls to
82 %, and the corresponding binding affinity threshold
value is 1425 nM.
The reason for this dramatic change in performance
when using percentile rank scores as opposed to affinity
is the large diversity in the range of binding values for
the different MHC molecules. This difference has been
observed in earlier studies and is maintained in the
method developed here [18]. If selecting peptides based
on binding affinity, priority will be given to MHC mole-
cules with generally higher affinity values compared to
molecules binding peptides with lower affinity, leading
to a highly unbalanced coverage of the different mole-
cules analyzed. We extracted subsets of peptides from
the total list of more than 4,800,000 peptides included in
the SYFPEITHI benchmark dataset based on predicted
binding affinity or percentile rank. Next, we compared
the proportion of peptide-restrictions to each MHC
molecule to the background distribution in the complete
dataset at different affinity or rank thresholds and quan-
tified the difference between the distributions in terms of
Information divergence (ID) [21] (see Implementation). If
the MHC restriction sampled in the selected subset is
similar to the background distribution, the resulting ID
value will be close to zero, and in case the distribution di-
verges from the background towards particular subsets of
MHC alleles, a large positive ID value is obtained. The re-
sults of this analysis are shown in the inset to Fig. 6 and
clearly demonstrate that the percentile rank selection in
contrast to the affinity-based selection for all peptide sub-
sets provides a sampling of the MHC space that is close to
identical to the background MHC distribution. Based on
these observations, we strongly recommend selecting can-
didate epitopes using percentile rank score as opposed to
predicted affinity, as they ensure a selection of peptides
that better represents the distribution of known peptide-
MHCs.
Discussion and conclusions
We have previously demonstrated how a simple neural
network-based machine learning algorithm, NNAlign,
can be effectively applied to identify binding motifs in
quantitative receptor-ligands datasets [22, 23], and have
with great success applied this method to learn the bind-
ing motifs and develop accurate prediction models for
the MHC class II system [24–26]. Likewise, we have re-
cently shown that the method can be extended to allow
for integration of information from peptides of variable
length and demonstrated how this leads to improved
prediction accuracy for allele-specific models in the con-
text of the MHC class I system, in particular for peptide
lengths different from the canonical binding core length
of 9 amino acids [15].
In this work, we have described how this approach
could be applied to a pan-specific MHC class I binding
prediction algorithm to obtain a significant improvement
in predictive performance in terms of predicted peptide-
MHC binders. We observed higher performance com-
pared to both the traditional pan-specific MHC class I
binding prediction method trained on 9mer peptide data
only (NetMHCpan-2.8) and the methods trained in an
allele-specific manner integrating information from pep-
tides of multiple length (NetMHC-4.0).
Similarly, we quantified the ability of the method to
identify experimentally confirmed MHC class I ligands.
In order to recover the known ligands at a sensitivity
level of 75 %, we estimated a close to 25 % reduction in
the number of peptides that need to be tested compared
to a conventional pan-specific method trained on 9mer
data only.
We applied the new prediction method to substanti-
ate why, when screening for potential binding pep-
tides to multiple MHC molecules, we recommend the
use of percentile rank scores rather than binding af-
finity values. From a large MHC class I ligand data-
set, we confirmed the previous finding [19] that MHC
class I molecules would be predicted to have peptide
repertoires of extremely different sizes, if they were
identified by a universal binding affinity threshold.
We demonstrated that this unbalance in the affinity
of the sampled peptide-space leads to a sub-optimal
predictive performance when screening for binding
peptides in a setting covering multiple MHC mole-
cules. Relying on percentile rank score for the selec-
tion of potential ligands can correct this unbalance
leading to improved predictive performance. In par-
ticular, we found that 91 % of the ligands would be
recovered with a specificity of 98 % using a percentile
rank score of 2 %. This sensitivity value drops to
82 % if the screening were based on affinity values.
While this study demonstrates that percentile rank
scores return a higher sensitivity in MHC ligand identifi-
cation compared to affinity scores (at a given specificity
value), the rank score approach starts from the extreme
assumption that the number of presented peptides is
identical for all MHC molecules. Earlier studies covering
a small set of alleles have suggested that this might not
always be the case [18]. Given this, and the observations
in our study, it seems plausible that the biologically rele-
vant threshold for identification of MHC ligands is
allele-specific and is based on a combination of percent-
ile ranks and affinity scores. However, since we cannot
quantify the size of the peptide repertoire of the many
thousands known MHC class I molecules and hence
cannot identify this biologically relevant binding thresh-
old, we suggest using percentile rank score, as this meas-
ure outperforms affinity-based selections.
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Another important property of the proposed method
is the ability to predict the binding mode of the peptide
to the receptor in terms of the binding core location,
both in the case of non-canonical binders protruding at
the termini [27] and for long peptides bulging out from
the center of the MHC groove with canonical C and N
terminal anchors [28]. While this property is also part of
the recently published NetMHC-4.0 method [15], it is to
the best of our knowledge for the first time described
here for a pan-specific MHC class I binding prediction
method.
Even though we have demonstrated how the extended
neural network-based machine learning NNAlign algo-
rithm overall enables the development of accurate pre-
diction models, these models are not any better than the
quality of the data used to train them. This is especially
true when it comes to the length distribution of binding
peptides predicted by the model for different receptors.
The predicted length distribution to a very high degree
reflects the length distribution in the data used to train
the model. If this distribution is at odds with the “true”
distribution of the given molecule, then the predicted
length distribution will also give a poor reflection of the
peptide length preference of the receptor. We can hope
that having developed a machine-learning algorithm that
readily can handle peptide datasets of multiple lengths,
the scientific community will benefit from this and ex-
pand the length space of peptides used for experimental
characterization of MHC molecules to ensure that these
match more closely what would be found in the bio-
logical setting. Indications of such length preferences
could be obtained from various experimental resources
including peptide libraries scans [29] and peptide MHC
mass spectrometry elution [30, 31].
In summary, we have applied the extended neural
network-based machine-learning algorithm to develop a
pan-specific prediction model for the MHC class I binding
system. It is clear that the application of this algorithm is
not limited to this system, and that it potentially can be
applied to a wide range of other receptor-ligand system
characterized with quantitative data including but not lim-
ited to MHC class II, SH2, SH3, and PDZ receptors.
Availability and requirements
The allmer method trained on the complete IEDB bind-
ing dataset is made freely available as a webserver
at www.cbs.dtu.dk/services/NetMHCpan-3.0.
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